Aarkstore Enterprise--ondine Biopharma Corporation (obp) - Financial And Strategic Analysis Review

Ondine Biopharma Corporation (OBP) - Financial and Strategic Analysis Review

Ondine Biopharma Corporation (Ondine) is a biotechnology company, that is engaged on the development and commercialization of non-antibiotic therapies for the treatment of a range of bacterial, fungal and viral infections. The company is focused on light activated technology, Photodisinfection (PDD) for multiple applications. Its one of the major product include MRSAid nasal decolonization system used to decolonize the nares of methicillin-resistant Staphylococcus aureus (MRSA). The companys commercial product developed from the PDD platform is Periowave, to treat periodontal disease (an inflammation of the gums).

Ondine Biopharma Corporation Key Recent Developments

May 14, 2010: Ondine Biopharma Reports Net Loss Of CAD1.14 Million For Q1 2010

Jan 07, 2010: Ondine Applies For Premarket Approval For Periowave

This comprehensive SWOT profile of Ondine Biopharma Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ondine Biopharma Corporation, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/Ondine-Biopharma-Corporation-OBP-Financial-and-Strategic-Analysis-Review-48923.html

Jessica

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com/

by: Aarkstore Enterprise

POST COMMENT

Do You Want To Start Day Trading? What Is Paper Trading? Trading In Round And Whole Numbers Building A Chicken Coop Rapidshare Be Cautious About Trading The Open! Focus Points For Successful Trading Pricing Calendar Spread Options - A Conservative Trading Plan Isabel De Los Rios Rapidshare Easy Backup Wizard Rapidshare Get acquainted with some day trading basics Preparing For Trading Options How To Choose The Right College? Use Strategic Plan Top Gun Options Your Resolution In Options Trading